Tag : treatment for lung cancer

Digital Health, Technology & Innovation

Median Files for CE Marking of AI Lung Cancer Tool eyonis® LCS

Business Wire
by Business Wire084
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a...
Healthcare Quality, Patient Safety & Policy

Revolution, Summit to Test RAS(ON) Drugs with Ivonescimab

Business Wire
by Business Wire081
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers and Summit Therapeutics Inc. (Nasdaq: SMMT), a...
Clinical Research, Pharma & Healthcare Financing

Circle Pharma Gets FDA Orphan Drug Status for CID-078 in SCLC

Business Wire
by Business Wire0105
Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...